A study analyzing the time to onset and magnitude of improvement across a number of different PROs in patients with RA
Latest Information Update: 28 Jun 2022
At a glance
- Drugs Baricitinib (Primary) ; Tofacitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
Most Recent Events
- 28 Jun 2022 New trial record
- 04 Jun 2022 Results presented at the 23rd Annual Congress of the European League Against Rheumatism